Europe Genomics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Sequencing, Microarray, Polymerase chain reaction (PCR), Nucleic Acid Extraction and Purification, and Others), Product & Service (Instruments/Systems, Consumables, and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research, and Others), End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, and Others), and Country

TIPRE00004302 | Pages: 258 | Biotechnology | Mar 2021 | Type: Regional | Status: Published

Market Introduction

Genomics is defined as the study of a gene and its functioning. Genomics is used to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. The major factors attributing to the growth of the genomics market are growing government support and increased number of genomics studies, declining sequencing cost, increased genomics applications.


Get more information on this report :



Market Overview and Dynamics

The Europe Genomics market is expected to reach US$ 15,448.81million in 2027 from US$ 6,023.69million in 2019. The market is estimated to grow with a CAGR of 12.8% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the extensive development in research and development activities concerning genomics market and the increase in government initiatives for growth in the genomics market. However, the market growth is likely to be hindered owing to the several challenges encountered regarding genomics market.

Key Market Segments

Based on technology, the genomics market is segmented into sequencing, microarray, PCR, nucleic acid extraction and purification, and others. Based on product and service, the genomics market is segmented into instruments/systems, consumables, and services.  Based on application, the genomics market, is segmented into diagnostics, drug discovery and development, precision/personalized medicine, agriculture & animal research, and others. Based on end-user, the genomics market, is segmented into research centers, hospitals and clinics, pharmaceutical & biotechnology companies, and others.

Major Sources and Companies Listed

Some of the major primary and secondary sources for genomics market included in the report are UK Synthetic Biology Strategic Plan, Precision Medicine Infrastructure Associated with Science and Technology (IMPACT), and others.

Reasons to buy the report

  • To understand the Europe Genomics market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Genomics market
  • Efficiently plan M&A and partnership deals in Europe Genomics market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Genomics market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region

 

EUROPE GENOMICS MARKET SEGMENTATION

By Technology

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

By Product and Services

  • Instruments/Systems
  • Consumables
  • Services

By Application

  • Diagnostics
  • Drug Discovery and Development
  • Precision/Personalized Medicine
  • Agriculture & Animal Research
  • Others

By End User

  • Research Centers
  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Companies
  • Others

By Country

  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Company Profiles

  • Illumina, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • General Electric Company

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Genomics Market – By Technology

1.3.2        Genomics Market – By Product& Services

1.3.3        Genomics Market – ByApplication

1.3.4        Genomics Market – By End User

1.3.5        EuropeGenomics Market– By Country

2.           EuropeGenomics Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           EuropeGenomics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Genomics Market- Europe PEST Analysis

4.3         Expert Opinion

5.           EuropeGenomics Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Extensive Development in Research and Development Activities ConcerningGenomics Market

5.1.2        Increase in Government Initiatives for Growth in the Genomics Market

5.2         Market Restraints

5.2.1        Several Challenges Encountered Regarding Genomics Market

5.3         Market Opportunities

5.3.1        Rapid Adoption of Personalized Medicines

5.4         Future Trends

5.4.1        Increasing Company Collaborations and Partnerships Regarding Genomics

5.5         Impact Analysis

6.           Genomics Market – Europe Analysis

6.1         EuropeGenomics Market Revenue Forecasts and Analysis

7.           EuropeGenomics Market Analysis and Forecasts To 2027 – ByTechnology

7.1         Overview

7.2         Genomics Market Revenue Share, by Technology (2019 and 2027)

7.3         Sequencing

7.3.1        Overview

7.3.2        Sequencing: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Microarray

7.4.1        Overview

7.4.2        Microarray: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Polymerase Chain Reaction (PCR)

7.5.1        Overview

7.5.2        Polymerase Chain Reaction (PCR): Genomics Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Nucleic Acid Extraction and Purification

7.6.1        Overview

7.6.2        Nucleic Acid Extraction and Purification: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

8.           Europe Genomics Market Analysis and Forecasts To 2027 – ByProduct and Service

8.1         Overview

8.2         Genomics Market Revenue Share, by Product & Service (2019 and 2027)

8.3         Instruments/Systems

8.3.1        Overview

8.3.2        Instruments/Systems: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Consumables

8.4.1        Overview

8.4.2        Consumables: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Services

8.5.1        Overview

8.5.2        Services: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

9.           EuropeGenomics Market Analysis – ByApplication

9.1         Overview

9.2         Genomics Market, by Application, 2019 and 2027 (%)

9.3         Diagnostics

9.3.1        Overview

9.3.2        Diagnostics: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Drug Discovery and Development

9.4.1        Overview

9.4.2        Drug Discovery and Development: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Precision/Personalized Medicine

9.5.1        Overview

9.5.2        Precision/Personalized Medicine: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

9.6         Agricultural & Animal Research

9.6.1        Overview

9.6.2        Agricultural & Animal Research: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

9.7         Others

9.7.1        Overview

9.7.2        Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

10.        EuropeGenomics Market Analysis – By End-User

10.1      Overview

10.2      Genomics Market, by End-User, 2019 and 2027 (%)

10.3      ResearchCentres

10.3.1     Overview

10.3.2     ResearchCentres: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

10.4      Hospitals& Clinics

10.4.1     Overview

10.4.2     Hospitals & Clinics: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

10.5      Pharmaceutical & Biotechnology Companies

10.5.1     Overview

10.5.2     Pharmaceutical & Biotechnology Companies: Genomics Market – Revenue and Forecast to 2027  (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

11.        Genomics Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1      Europe: Genomics Market

11.1.1     Overview

11.1.2     Europe: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.3     Europe: Genomics Market, by Technology, 2018–2027 (USD Million)

11.1.4     Europe: Genomics Market, by Product and Service, 2018–2027 (USD Million)

11.1.5     Europe: Genomics Market, by Application, 2018–2027 (Million Units)

11.1.6     Europe: Genomics, Market, by End User, 2018–2027 (USD Million)

11.1.7     Europe: Genomics Market, by Country, 2019 & 2027 (%)

11.1.8     UK: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       UK: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       UK: Genomics Market, by Technology, 2018–2027 (USD Million)

11.1.8.3       UK: Genomics Market, by Product and Service, 2018–2027 (USD Million)

11.1.8.4       UK: Genomics Market, by Application, 2018–2027 (Million Units)

11.1.8.5       UK: Genomics, Market, by End User, 2018–2027 (USD Million)

11.1.9     Germany: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       Germany: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       Germany: Genomics Market, by Technology, 2018–2027 (USD Million)

11.1.9.3       Germany: Genomics Market, by Product and Service, 2018–2027 (USD Million)

11.1.9.4       Germany: Genomics Market, by Application, 2018–2027 (Million Units)

11.1.9.5       Germany: Genomics, Market, by End User, 2018–2027 (USD Million)

11.1.10  France: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    France: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    France: Genomics Market, by Technology, 2018–2027 (USD Million)

11.1.10.3    France: Genomics Market, by Product and Service, 2018–2027 (USD Million)

11.1.10.4    France: Genomics Market, by Application, 2018–2027 (Million Units)

11.1.10.5    France: Genomics, Market, by End User, 2018–2027 (USD Million)

11.1.11  Italy: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.1    Italy: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.2    Italy: Genomics Market, by Technology, 2018–2027 (USD Million)

11.1.11.3    Italy: Genomics Market, by Product and Service, 2018–2027 (USD Million)

11.1.11.4    Italy: Genomics Market, by Application, 2018–2027 (Million Units)

11.1.11.5    Italy: Genomics, Market, by End User, 2018–2027 (USD Million)

11.1.12  Spain: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.1    Spain: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.2    Spain: Genomics Market, by Technology, 2018–2027 (USD Million)

11.1.12.3    Spain: Genomics Market, by Product and Service, 2018–2027 (USD Million)

11.1.12.4    Spain: Genomics Market, by Application, 2018–2027 (Million Units)

11.1.12.5    Spain: Genomics, Market, by End User, 2018–2027 (USD Million)

11.1.13  Rest of Europe: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.13.1    Rest of Europe: Genomics Market – Revenue and Forecast to 2027 (USD Million)

11.1.13.2    Rest of Europe: Genomics Market, by Technology, 2018–2027 (USD Million)

11.1.13.3    Rest of Europe: Genomics Market, by Product and Service, 2018–2027 (USD Million)

11.1.13.4    Rest of Europe: Genomics Market, by Application, 2018–2027 (Million Units)

11.1.13.5    Rest of Europe: Genomics, Market, by End User, 2018–2027 (USD Million)

12.        Impact of COVID-19 Pandemic on EuropeGenomics Market

12.1      Europe: Impact Assessment of COVID-19 Pandemic

13.        COMPANY PROFILES

13.1      Illumina, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4       Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Danaher

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      F. HOFFMANN-LA ROCHE LTD.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      BIO-RAD LABORATORIES INC.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      General Electric Company

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6       Key Developments

13.6      THERMO FISHER SCIENTIFIC INC.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Agilent Technologies, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Eurofins Scientific

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      QIAGEN

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   BGI

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6    Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of terms

LIST OF TABLES

Table 1.             Europe: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 2.             Europe: Genomics Market, by Product and Service– Revenue and Forecast to 2027 (USD Million)

Table 3.             Europe: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)

Table 4.             Europe: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 5.             UK: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 6.             UK: Genomics Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 7.             UK: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)

Table 8.             UK: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 9.             Germany: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 10.          Germany: Genomics Market, by Product and Service– Revenue and Forecast to 2027 (USD Million)

Table 11.          Germany: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)

Table 12.          Germany: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          France: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 14.          France: Genomics Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 15.          France: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)

Table 16.          France: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17.          Italy: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 18.          Italy: Genomics Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 19.          Italy: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)

Table 20.          Italy: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Spain: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 22.          Spain: Genomics Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 23.          Spain: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)

Table 24.          Spain: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 25.          Rest of Europe: Genomics Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 26.          Rest of Europe: Genomics Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 27.          Rest of Europe: Genomics Market, by Application– Revenue and Forecast to 2027 (Million Units)

Table 28.          Rest of Europe: Genomics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 29.          Glossary of Terms,Genomics Market

 

LIST OF FIGURES

Figure 1.           GenomicsMarket Segmentation

Figure 2.           EuropeGenomics Market Overview

Figure 3.           SequencingSegment Held Largest Share of Technology inGenomicsMarket

Figure 4.           Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Genomics Market - Europe PEST Analysis

Figure 6.           Genomics Market Impact Analysis of Driver and Restraints

Figure 7.           EuropeGenomics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Genomics Market Revenue Share, by Technology (2019 and 2027)

Figure 9.           Sequencing: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Microarray: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Polymerase Chain Reaction (PCR): Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Nucleic Acid Extraction and Purification: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Genomics Market Revenue Share, by Product & Service (2019 and 2027)

Figure 15.        Instruments/Systems: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Consumables: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Services: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Genomics Market, by Application, 2019 and 2027 (%)

Figure 19.        Diagnostics: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Drug Discovery and Development: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Precision/Personalized Medicine: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Agricultural & Animal Research: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Others: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Genomics Market, by End-User, 2019 and 2027 (%)

Figure 25.        Research Centers: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Hospitals & Clinics: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Pharmaceutical & Biotechnology Companies: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Other End-Users: Genomics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Europe: Genomics Market, by Key Country – Revenue (2019) (USD Million)

Figure 30.        Europe: Genomics Market Revenue and Forecast to 2027 (USD Million)

Figure 31.        Europe: Genomics Market, by Country, 2019 & 2027 (%)

Figure 32.        UK: Genomics Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        Germany: Genomics Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        France: Genomics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Italy: Genomics Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Spain: Genomics Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Rest of Europe: Genomics Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Impact of COVID-19 Pandemic in Europe Country Markets

 

  1. Illumina, Inc.
  2. Danaher
  3. F. HOFFMANN-LA ROCHE LTD.
  4. BIO-RAD LABORATORIES INC.
  5. General Electric Company
  6. THERMO FISHER SCIENTIFIC INC.
  7. Agilent Technologies, Inc.
  8. Eurofins Scientific
  9. QIAGEN
  10. BGI
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe genomics market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the Europe genomics market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.

 

  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000